| pubmed-article:11157249 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11157249 | lifeskim:mentions | umls-concept:C1533591 | lld:lifeskim |
| pubmed-article:11157249 | lifeskim:mentions | umls-concept:C0870883 | lld:lifeskim |
| pubmed-article:11157249 | lifeskim:mentions | umls-concept:C0205360 | lld:lifeskim |
| pubmed-article:11157249 | lifeskim:mentions | umls-concept:C1998793 | lld:lifeskim |
| pubmed-article:11157249 | lifeskim:mentions | umls-concept:C0057781 | lld:lifeskim |
| pubmed-article:11157249 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:11157249 | pubmed:dateCreated | 2001-2-22 | lld:pubmed |
| pubmed-article:11157249 | pubmed:abstractText | 3-Hydroxy-2-formylbenzothiophene (HFBT) is a metabolite found in many bacterial cultures that degrade dibenzothiophene (DBT) via the Kodama pathway. The fate of HFBT in cultures and in the environment is unknown. In this study, HFBT was produced by a DBT-degrading bacterium and purified by sublimation. When stored in organic solvent or as a crystal, the HFBT slowly decomposed, yielding colored products. Two of these were identified as thioindigo and cis-thioindigo. The supernatant of the DBT-degrading culture contained thioindigo, which has not been reported previously as a product of DBT biodegradation. In mineral salts medium, HFBT was sufficiently stable to allow biodegradation studies with a mixed microbial culture over a 3- to 4-week period. High-performance liquid chromatography analyses showed that HFBT was removed from the medium. 2-Mercaptophenylglyoxalate, detected as benzothiophene-2,3-dione, was found in an HFBT-degrading mixed culture, and the former appears to be a metabolite of HFBT. This mixed culture also mineralized HFBT to CO2. | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11157249 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11157249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11157249 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11157249 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:11157249 | pubmed:issn | 0099-2240 | lld:pubmed |
| pubmed-article:11157249 | pubmed:author | pubmed-author:FedorakP MPM | lld:pubmed |
| pubmed-article:11157249 | pubmed:author | pubmed-author:BresslerD CDC | lld:pubmed |
| pubmed-article:11157249 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11157249 | pubmed:volume | 67 | lld:pubmed |
| pubmed-article:11157249 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11157249 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11157249 | pubmed:pagination | 821-6 | lld:pubmed |
| pubmed-article:11157249 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:11157249 | pubmed:meshHeading | pubmed-meshheading:11157249... | lld:pubmed |
| pubmed-article:11157249 | pubmed:meshHeading | pubmed-meshheading:11157249... | lld:pubmed |
| pubmed-article:11157249 | pubmed:meshHeading | pubmed-meshheading:11157249... | lld:pubmed |
| pubmed-article:11157249 | pubmed:meshHeading | pubmed-meshheading:11157249... | lld:pubmed |
| pubmed-article:11157249 | pubmed:meshHeading | pubmed-meshheading:11157249... | lld:pubmed |
| pubmed-article:11157249 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11157249 | pubmed:articleTitle | Purification, stability, and mineralization of 3-hydroxy-2- formylbenzothiophene, a metabolite of dibenzothiophene. | lld:pubmed |
| pubmed-article:11157249 | pubmed:affiliation | Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada T6G 2E9. | lld:pubmed |
| pubmed-article:11157249 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11157249 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11157249 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11157249 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11157249 | lld:pubmed |
